BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

860 related articles for article (PubMed ID: 29029710)

  • 1. Systemic Thrombolysis for Pulmonary Embolism: Who and How.
    Tapson VF; Friedman O
    Tech Vasc Interv Radiol; 2017 Sep; 20(3):162-174. PubMed ID: 29029710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter-Based Approaches for the Treatment of Acute Pulmonary Embolism.
    Tapson VF; Jimenez D
    Semin Respir Crit Care Med; 2017 Feb; 38(1):73-83. PubMed ID: 28208201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of systemic thrombolysis in acute submassive intermediate risk pulmonary embolism: review and future perspectives.
    Teleb M; Porres-Aguilar M; Anaya-Ayala JE; Rodriguez-Castro C; Porres-Muñoz M; Mukherjee D
    Ther Adv Cardiovasc Dis; 2016 Apr; 10(2):103-10. PubMed ID: 26864121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming and simplifying the treatment of pulmonary embolism: "safe dose" thrombolysis plus new oral anticoagulants.
    Sharifi M; Vajo Z; Freeman W; Bay C; Sharifi M; Schwartz F
    Lung; 2015 Jun; 193(3):369-74. PubMed ID: 25749665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventional Treatment of Pulmonary Embolism.
    Dudzinski DM; Giri J; Rosenfield K
    Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28213377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter-Directed Thrombolysis for Pulmonary Embolism: The State of Practice.
    Xue X; Sista AK
    Tech Vasc Interv Radiol; 2018 Jun; 21(2):78-84. PubMed ID: 29784125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.
    Avgerinos ED; Saadeddin Z; Abou Ali AN; Fish L; Toma C; Chaer M; Rivera-Lebron BN; Chaer RA
    J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):530-540. PubMed ID: 29909859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should thrombolytic therapy be used in patients with pulmonary embolism?
    Konstantinides S
    Am J Cardiovasc Drugs; 2004; 4(2):69-74. PubMed ID: 15049719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Thrombolysis, Catheter-Directed Thrombolysis, and Anticoagulation for Intermediate-risk Pulmonary Embolism: A Simulation Modeling Analysis.
    Kabrhel C; Ali A; Choi JG; Hur C
    Acad Emerg Med; 2017 Oct; 24(10):1235-1243. PubMed ID: 28650086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
    Long B; Koyfman A
    J Emerg Med; 2016 Jul; 51(1):37-44. PubMed ID: 27071316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical update on thrombolytic use in pulmonary embolism: A focus on intermediate-risk patients.
    Eberle H; Lyn R; Knight T; Hodge E; Daley M
    Am J Health Syst Pharm; 2018 Sep; 75(17):1275-1285. PubMed ID: 29895520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.
    Mohan PP; Manov JJ; Contreras F; Langston ME; Doshi MH; Narayanan G
    Vasc Endovascular Surg; 2018 Apr; 52(3):195-201. PubMed ID: 29436310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Risk Pulmonary Embolism: Current Evidence-Based Practices.
    Theroux CD; Aliotta JM; Mullin CJ
    R I Med J (2013); 2019 Dec; 102(10):43-47. PubMed ID: 31795534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of life-threatening pulmonary embolism.
    Marshall PS; Mathews KS; Siegel MD
    J Intensive Care Med; 2011; 26(5):275-94. PubMed ID: 21606060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: Clinical efficacy but attendant hemorrhagic risks.
    Rothschild DP; Goldstein JA; Bowers TR
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):506-510. PubMed ID: 30549393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis for acute pulmonary embolism.
    Piazza G; Goldhaber SZ
    Vasc Med; 2010 Oct; 15(5):419-28. PubMed ID: 20926501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic or local thrombolysis in high-risk pulmonary embolism.
    Macovei L; Presura RM; Arsenescu Georgescu C
    Cardiol J; 2015; 22(4):467-74. PubMed ID: 25563712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
    Islam MS
    Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute phase treatment of venous thromboembolism: advanced therapy. Systemic fibrinolysis and pharmacomechanical therapy.
    Konstantinides SV; Wärntges S
    Thromb Haemost; 2015 Jun; 113(6):1202-9. PubMed ID: 25789580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
    Piazza G; Hohlfelder B; Jaff MR; Ouriel K; Engelhardt TC; Sterling KM; Jones NJ; Gurley JC; Bhatheja R; Kennedy RJ; Goswami N; Natarajan K; Rundback J; Sadiq IR; Liu SK; Bhalla N; Raja ML; Weinstock BS; Cynamon J; Elmasri FF; Garcia MJ; Kumar M; Ayerdi J; Soukas P; Kuo W; Liu PY; Goldhaber SZ;
    JACC Cardiovasc Interv; 2015 Aug; 8(10):1382-1392. PubMed ID: 26315743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.